logo
Exact date 'hostile alien probe' could strike Earth revealed as Harvard scientist issues chilling warning

Exact date 'hostile alien probe' could strike Earth revealed as Harvard scientist issues chilling warning

Daily Mail​4 days ago
A Harvard scientist has issued a chilling warning about a mysterious interstellar object hurtling through our solar system, and says it could spell disaster for Earth.
Professor Avi Loeb, who is well-known for pushing bold and often polarizing theories about extraterrestrial life, has been tracking the object, named 3I/ATLAS, since it was first spotted on July 1.
If the object is an alien craft, Loeb warned it could be carrying a probe or even a weapon. He predicted that such an intercept vehicle would reach Earth between November 21 and December 5, 2025.
The timeline is based on calculations that 3I/ATLAS will pass behind the sun from Earth's perspective this October, a time he ominously suggested could be used to prepare the attack.
Referring to the object as a 'mothership,' he explained that its position would be an efficient way to seed habitable planets with probes.
This strategy would allow the devices to 'intercept the planets while the mothership continues on its journey to the next star.'
'It may come to save us or destroy us. We'd better be ready for both options and check whether all interstellar objects are rocks,' said Loeb.
Chris Lintott, an astronomer at the University of Oxford, has dismissed Loeb's claims as 'nonsense on stilts,' telling Live Science that the alien probe theory is an 'insult to the exciting work going on to understand this object.'
Loeb has remained adamant that something about 3I/ATLAS does not add up.
He said its retrograde orbit, meaning it's moving against the flow of the solar system, is oddly aligned with Earth's path.
'3I/ATLAS might be an alien probe,' he said, citing its 'unusually rare trajectory,' which just so happens to align closely with the orbital plane of the inner planets, including Earth.
He puts the odds of that happening naturally at just 0.2 percent.
'At its closest point to the sun on October 29, fears of an alien invasion could send stock markets crashing,' Loeb said. 'In that scenario, citizens would lose their trust in governments to protect them.'
He went so far as to compare the potential chaos to a military ambush, saying: 'Facing a high-tech alien visitor could feel like Iran's air defenses when US B-2 bombers appeared, silent, unstoppable, and overwhelmingly powerful.'
The object, believed to be about 12 miles wide, is unusually large for something hurtling in from outside the solar system.
According to Loeb, if it were natural, we would have already spotted millions of similar objects. 'But we haven't,' he said.
He has published three pre-print papers laying out the case and has even suggested that NASA attempt an interception using its Juno spacecraft when the object passes near Jupiter.
'In my view, we need a risk scale for interstellar objects,' Loeb said. 'A zero would be a natural comet.
'A 10 would be a verified technological object, possibly powered by an engine or emitting artificial light.'
He also believes governments should already be forming task forces, including scientists, policymakers and even psychologists, to determine how to respond and how to break the news to the public without triggering panic.
Loeb's warnings have grown increasingly urgent, culminating in one dramatic statement: 'It may come to save us or destroy us. We'd better be ready for both options.'
If 3I/ATLAS is more than just a rock, he said Earth is woefully unprepared.
'The visitor,' he warned, 'is already in our backyard.'
Even if the object turns out to be artificial, Loeb admitted there's little humanity could do.
At nearly 60 miles per second relative to Earth, it's moving far too fast for any of our current rockets to reach.
'If the hypothesis that 3I/ATLAS is a technological artifact proves correct, there are two possible implications: either its intentions are entirely benign, or they are malign, said Loeb.
'In the first case, humanity need only wait and welcome this interstellar messenger with open arms. It is the second scenario that causes serious concern.'
He added that because the second possibility has serious consequences, we can use the idea behind Pascal's wager.
'Blaise Pascal argued that it's smarter to believe in God because the possible benefits of believing are much greater than the losses if you're wrong,' Loeb explained.
'Similarly, in our case, it makes sense to warn humanity about the risk from 3I/ATLAS, even if it turns out to be just a theory.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr. pulls $500 million in funding for vaccine development
RFK Jr. pulls $500 million in funding for vaccine development

The Independent

time4 minutes ago

  • The Independent

RFK Jr. pulls $500 million in funding for vaccine development

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu. Robert F. Kennedy Jr., the health secretary and a longtime vaccine critic, announced in a statement Tuesday that $500 million worth of vaccine development projects, all using mRNA technology, will be halted. The projects — 22 of them — are being led by some of the nation's leading pharmaceutical companies like Pfizer and Moderna to prevent flu, COVID-19 and H5N1 infections. The mRNA vaccines are credited with slowing the 2020 coronavirus pandemic. Kennedy said in the Tuesday statement that he wants the health department to move away from mRNA vaccines, calling on the department to start 'investing in better solutions.' He provided no details on what those technologies might be.

US health agency to wind down mRNA vaccine development
US health agency to wind down mRNA vaccine development

Reuters

time34 minutes ago

  • Reuters

US health agency to wind down mRNA vaccine development

Aug 5 (Reuters) - The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under its biomedical research unit. The unit, Biomedical Advanced Research and Development Authority, helps companies develop medical supplies to address public health threats, and had also provided billions of dollars for development of COVID-19 vaccines during the pandemic. HHS said the wind down includes cancellation of a contract awarded to Moderna (MRNA.O), opens new tab for the late-stage development of its bird flu vaccine for humans and the right to purchase the shots, a move first reported in May. The U.S. health agency said it is also rejecting or canceling multiple pre-award solicitations, including proposals from Pfizer (PFE.N), opens new tab, Sanofi Pasteur ( opens new tab, CSL Seqirus ( opens new tab, Gritstone and others. In total, this affects 22 projects worth nearly $500 million, the agency said. HHS said the decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.

Ozempic could be hurting your gym gains — with potentially dangerous consequences
Ozempic could be hurting your gym gains — with potentially dangerous consequences

The Independent

time2 hours ago

  • The Independent

Ozempic could be hurting your gym gains — with potentially dangerous consequences

The popular weight loss drug Ozempic has been used by millions of Americans for years. Now, researchers warn that the drug has shown some concerning impacts to muscle mass and strength in mice. New findings suggest muscle mass is altered less than expected while taking the diabetes drug, but that muscles may still get weaker over time. Ozempic-induced weight loss decreased lean mass — or muscle mass without fat — by around 10 percent, the University of Utah Health team said. Most of that weight loss was from tissue and the liver; the organ shrunk by nearly half its size. Some skeletal muscles, which are attached to bones and responsible for movement, also shrank, while other muscles remained the same size as before Ozempic. "In clinical trials for Wegovy or Ozempic we did not specifically study the medicine's impact on muscle mass. In a sub-study of 140 patients with a BMI of 40 or less conducted as part of the STEP 1 trial, dual-energy x-ray absorptiometry (DEXA) analyses suggested that treatment with Wegovy® was accompanied by reductions in both fat mass and lean body mass, with a greater reduction in fat mass than lean body mass," a spokesperson for Novo Nordisk told The Independent on Tuesday. "We recommend that any patients experiencing side effects while taking Wegovy or Ozempic contact their healthcare provider," they said. Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according to the Cleveland Clinic. It's a condition often linked to obesity, osteoporosis, arthritis, and chronic diseases, including cancer. Still, the study was done in mice and not humans. More research needs to be done to understand if similar changes to organ size could happen in humans and if there are any associated health risks. Notably, loss of organ mass, including the liver, is expected as a part of healthy weight loss, without affecting the organs' function. loss of fat can also result in loss of muscle without affecting the overall quality of life, the researchers noted. 'If we want to really help the individuals who may be losing muscle mass, then we need to know that they're actually losing muscle mass,' Dr. Katsu Funai, an associate professor of nutrition and integrative physiology in the University of Utah College of Health, said in a statement. 'We have data in mice that suggest that things are not as straightforward as they might seem.' But, it's not just muscle mass that was affected. In tests of force and strength, some of the mice muscles' strength decreased as they lost weight — even without losing muscle mass. But, in others, strength was unchanged. Why this happens is not yet understood, but in older humans, losing strength while taking Ozempic could be particularly worrisome. 'The loss of physical function is a strong predictor of not just quality of life but longevity,' Funai said. Of course, previous research has found Ozempic to have more beneficial side effects, in addition to helping address the nation's obesity epidemic. A new study linked Ozempic to slower rates of aging, according to New Scientist. That builds on similar research released last year. The drug has also been tied to a reduced risk of dementia in people with type 2 diabetes, and protection against heart disease. Ozempic has not been approved by the U.S. Food and Drug Administration. Regardless of their findings, the researchers warned people not to draw hasty and unfounded conclusions. In people, for example, obesity is associated with less physical activity, whereas mice don't become less active. Humans also become overweight for a multitude of factors, including genetics and age. For mice, it was because they ate a diet that was high in fat. 'There remains a significant need for validation in humans, especially concerning muscle strength,' Dr. Takuya Karasawa, a postdoctoral researcher at the university's molecular medicine program, said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store